Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy

被引:10
作者
Davey, Angela [1 ]
van Herk, Marcel [1 ,2 ]
Faivre-Finn, Corinne [1 ,2 ,3 ]
Brown, Sean [2 ,3 ]
McWilliam, Alan [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, Dept Radiotherapy Related Res, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England
关键词
radiomics; 4D-CT; lung cancer; SABR; personalised; biomarkers; MACHINE LEARNING-METHODS; ABLATIVE RADIOTHERAPY; CT; FEATURES; IMAGES; RECURRENCE; UNCERTAINTY; VARIABILITY; DELINEATION; STABILITY;
D O I
10.1088/1361-6560/abfa34
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose. 4D-CT is routine imaging for lung cancer patients treated with stereotactic body radiotherapy. No studies have investigated optimal 4D phase selection for radiomics. We aim to determine how phase data should be used to identify prognostic biomarkers for distant failure, and test whether stability assessment is required. A phase selection approach will be developed to aid studies with different 4D protocols and account for patient differences. Methods. 186 features were extracted from the tumour and peritumour on all phases for 258 patients. Feature values were selected from phase features using four methods: (A) mean across phases, (B) median across phases, (C) 50% phase, and (D) the most stable phase (closest in value to two neighbours), coined personalised selection. Four levels of stability assessment were also analysed, with inclusion of: (1) all features, (2) stable features across all phases, (3) stable features across phase and neighbour phases, and (4) features averaged over neighbour phases. Clinical-radiomics models were built for twelve combinations of feature type and assessment method. Model performance was assessed by concordance index (c-index) and fraction of new information from radiomic features. Results. The most stable phase spanned the whole range but was most often near exhale. All radiomic signatures provided new information for distant failure prediction. The personalised model had the highest c-index (0.77), and 58% of new information was provided by radiomic features when no stability assessment was performed. Conclusion. The most stable phase varies per-patient and selecting this improves model performance compared to standard methods. We advise the single most stable phase should be determined by minimising feature differences to neighbour phases. Stability assessment over all phases decreases performance by excessively removing features. Instead, averaging of neighbour phases should be used when stability is of concern. The models suggest that higher peritumoural intensity predicts distant failure.
引用
收藏
页数:14
相关论文
共 56 条
  • [1] [Anonymous], 2019, STER ABL BOD RAD THE
  • [2] Davey A, 2020, RADIOTHER ONCOL, V152, pS44
  • [3] Automated gross tumor volume contour generation for large-scale analysis of early-stage lung cancer patients planned with 4D-CT
    Davey, Angela
    van Herk, Marcel
    Faivre-Finn, Corinne
    Brown, Sean
    McWilliam, Alan
    [J]. MEDICAL PHYSICS, 2021, 48 (02) : 724 - 732
  • [4] Is tumour sphericity an important prognostic factor in patients with lung cancer?
    Davey, Angela
    van Herk, Marcel
    Faivre-Finn, Corinne
    Mistry, Hitesh
    McWilliam, Alan
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 143 : 73 - 80
  • [5] mRMRe: an R package for parallelized mRMR ensemble feature selection
    De Jay, Nicolas
    Papillon-Cavanagh, Simon
    Olsen, Catharina
    El-Hachem, Nehme
    Bontempi, Gianluca
    Haibe-Kains, Benjamin
    [J]. BIOINFORMATICS, 2013, 29 (18) : 2365 - 2368
  • [6] Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC
    Dou, Tai H.
    Coroller, Thibaud P.
    van Griethuysen, Joost J. M.
    Mak, Raymond H.
    Aerts, Hugo J. W. L.
    [J]. PLOS ONE, 2018, 13 (11):
  • [7] Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction
    Du, Qian
    Baine, Michael
    Bavitz, Kyle
    McAllister, Josiah
    Liang, Xiaoying
    Yu, Hongfeng
    Ryckman, Jeffrey
    Yu, Lina
    Jiang, Hengle
    Zhou, Sumin
    Zhang, Chi
    Zheng, Dandan
    [J]. PLOS ONE, 2019, 14 (05):
  • [8] Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer?
    Fave, Xenia
    Mackin, Dennis
    Yang, Jinzhong
    Zhang, Joy
    Fried, David
    Balter, Peter
    Followill, David
    Gomez, Daniel
    Jones, A. Kyle
    Stingo, Francesco
    Fontenot, Jonas
    Court, Laurence
    [J]. MEDICAL PHYSICS, 2015, 42 (12) : 6784 - 6797
  • [9] Preliminary investigation into sources of uncertainty in quantitative imaging features
    Fave, Xenia
    Cook, Molly
    Frederick, Amy
    Zhang, Lifei
    Yang, Jinzhong
    Fried, David
    Stingo, Francesco
    Court, Laurence
    [J]. COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2015, 44 : 54 - 61
  • [10] Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype
    Fornacon-Wood, Isabella
    Faivre-Finn, Corinne
    O'Connor, James P. B.
    Price, Gareth J.
    [J]. LUNG CANCER, 2020, 146 : 197 - 208